News
Media
Around the PracticeBetween The LinesCase-Based Peer PerspectiveClinical Case CollectiveDermViewExpert PerspectivesFellows Face OffFrontline ForumMedical World NewsPatient PerspectivesPodcastsReadout360Recognize and Refer
Conferences
Conference CoverageConference Listing
Events
Case-Based Roundtable
Publication
Dermatology Times
More
CME/CE
Resources
DermIQInteractive ToolsJob BoardPartner PerspectivesPerspectives in DermatologyPollsSponsored ContentSponsored ResourcesSpot Test
Editorial Advisory Board
Partners

Subscribe

  • News
  • Media
  • Conferences
  • Events
  • Publication
  • CME/CE
  • Resources
  • Editorial Advisory Board
  • Partners
  • Subscribe
  • Acne
  • Actinic Keratosis
  • Aesthetics
  • Alopecia
  • Atopic Dermatitis
  • Buy-and-Bill
  • COVID-19
  • Case-Based Roundtable
  • Chronic Hand Eczema
  • Chronic Spontaneous Urticaria
  • Drug Watch
  • Eczema
  • General Dermatology
  • Hidradenitis Suppurativa
  • Melasma
  • Pediatric Dermatology
  • Pigmentary Disorders
  • Practice Management
  • Precision Medicine and Biologics
  • Prurigo Nodularis
  • Psoriasis
  • Psoriatic Arthritis
  • Rare Disease
  • Rosacea
  • Skin Cancer
    • Non-Melanoma Skin Cancers
  • Vitiligo
  • Wound Care
Spotlight -
Dermatology Times NP/PA Connect
Advertisement

Stella Kyaw-Soe, PharmD, MBA, Sanofi, Cambridge, USA

Advertisement

Articles by Stella Kyaw-Soe, PharmD, MBA, Sanofi, Cambridge, USA

OX40-Ligand: A Conductor of the Atopic Dermatitis Inflammatory Symphony?

ByApril W. Armstrong, MD, MPH, Professor and Chief of Dermatology​, University of California, Los Angeles​,Kassim Rahawi, PharmD, Sanofi, Cambridge, USA,Wendell Valdecantos, MD, Sanofi, Cambridge, USA,Stella Kyaw-Soe, PharmD, MBA, Sanofi, Cambridge, USA
October 22nd 2024

Given the complexity of the underlying inflammation in patients with AD, an increased understanding of the OX40L pathway can improve our understanding of AD pathogenesis.

Advertisement

Latest Updated Articles

  • OX40-Ligand: A Conductor of the Atopic Dermatitis Inflammatory Symphony?
    OX40-Ligand: A Conductor of the Atopic Dermatitis Inflammatory Symphony?

    Published: October 22nd 2024 | Updated:



Advertisement
Advertisement

Trending on Dermatology Times

1

Clinicians See Intersection of Weight Loss and Facial Aging

2

Soquelitinib Phase 1 Data Show Sustained Clinical Improvement With Extended Treatment in AD

3

The “6-7” Advances for Dermatologists to Look Forward to in 2026

4

Q&A: Saami Khalifian, MD, FAAD, on Integrating BOTOX Cosmetic into Lower Face and Neck Rejuvenation

5

Quoin Targets World’s First Approval for Netherton Syndrome Therapy in Saudi Arabia

  • About
  • Advertise
  • Contact Us
  • Job Board
  • Do Not Sell My Information
  • Terms and Conditions
  • Privacy Policy
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us